---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-027861"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-06-09T12:30:22+00:00"
generated_at: "2026-06-09T12:35:18.470389+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical secures first Midwest account, Michigan health system adopts LIBERTY System

## Summary
- First Midwest-based account: a large Michigan healthcare system adopts LIBERTY Endovascular Robotic System.
- Follows recent expansion into North Carolina, reflecting growing U.S. presence after full market release.
- LIBERTY also received regulatory approval from Israel Ministry of Health to market and sell in Israel.
- U.S. market for peripheral endovascular procedures approximately 2.5 million annually.
- CEO Harel Gadot cites increasing interest from physicians and hospital leaders.

## SEC filing metadata
- accession: 0001493152-26-027861
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-06-09T12:30:22+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226027861/0001493152-26-027861-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226027861/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-027861
- JSON: https://secwatch.observer/filing/0001493152-26-027861.json
- Plain text: https://secwatch.observer/filing/0001493152-26-027861.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.